Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 5.5% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis (ACB) is a leading Canadian cannabis company that has been navigating through a volatile market environment. The company has been focusing on global medical cannabis expansion and strategic shifts to drive growth amidst regulatory challenges.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 5.5% on Jun 12, 2026 15:16

• Despite a wider loss in the fourth quarter due to increased costs, Aurora Cannabis reported strong Q4 2026 financial results, exceeding revenue expectations and emphasizing growth in global medical cannabis.
• The announcement of a decline in fiscal year 2027 total net revenue and revised revenue forecasts for the second quarter of fiscal 2020 led to a negative investor reaction, causing a drop in share prices.
• The company's strategic priorities, including a shift towards high-margin global medical cannabis and international expansion, indicate a long-term growth strategy despite short-term revenue challenges.
• Aurora Cannabis's upcoming earnings report will be crucial in providing insights into its financial health and addressing concerns about profitability and growth, potentially influencing investor sentiment and market movement.

ACB Price Chart

ACB Technical Analysis

ACB News

Aurora Cannabis 4Q Loss Widens on Higher Costs

Aurora Cannabis reported a wider loss in its fourth quarter due to increased costs, despite a rise in revenue. The company's net loss reached CAD$25.2 million, up from CAD$17.3 million in the previous year's quarter. This was attributed to higher selling, general, and administrative expenses, as well as increased depreciation and amortization.

https://www.moomoo.com/news/post/71395355/aurora-cannabis-4q-loss-widens-on-higher-costs?futusource=news_newspage_recommend

Aurora Cannabis Down 4% in U.S. Pre-Market After It Forecast a Decline in Fiscal Year 2027 Total Net Revenue

Aurora Cannabis Inc. (ACB) saw its shares drop 4% in U.S. pre-market trading after the company forecast a decline in its fiscal year 2027 total net revenue. The company also announced a new investor day presentation, which highlighted its strategic priorities and financial outlook. This news has led to a negative reaction from investors ahead of market open.

https://www.moomoo.com/news/post/71396080/aurora-cannabis-down-4-in-us-pre-market-after-it

Aurora Cannabis Shares Touch Three-Year Low on Expected Revenue Decline

Aurora Cannabis Inc. shares fell to a three-year low after the company announced it expects a decline in second-quarter fiscal 2020 revenue compared to the previous quarter. The company cited slower-than-anticipated retail store openings in Canada and a slower rollout of cannabis 2.0 products, leading to a revised revenue forecast between C$50 million and C$54 million. This news comes after a series of management changes and a significant increase in outstanding shares, further impacting investor confidence.

https://www.moomoo.com/news/post/71406820/aurora-cannabis-shares-touch-three-year-low-on-expected-revenue?futusource=news_newspage_recommend

Full Transcript: Aurora Cannabis Q4 2026 Earnings Call

Aurora Cannabis (ACB) reported strong Q4 2026 financial results, with net revenue exceeding expectations and global medical cannabis driving growth. The company is strategically shifting its focus from lower-margin Canadian consumer segments to high-margin global medical cannabis, bolstered by the acquisition of Safari Flower Co. While fiscal year 2027 is projected as a "reset year" due to changes in Canadian reimbursement rates, Aurora plans to continue investing in international expansion, particularly in Germany and Poland, and sees potential opportunities in the evolving U.S. market.

https://www.benzinga.com/insights/news/26/06/53138958/full-transcript-aurora-cannabis-q4-2026-earnings-call

Upcoming Earnings Reports: Aurora Cannabis (ACB) and More

Aurora Cannabis Inc. (ACB) is set to announce its earnings, which will provide key insights into its financial health, especially given the volatile cannabis market. The company, a small-cap stock with a market capitalization of $195.2 million, has a GF Score of 58/100 and a low financial strength rating of 4/10, suggesting potential risks for investors. Despite possibly being undervalued based on its P/S and P/B ratios, investors are advised to proceed with caution due to concerns about profitability and growth.

https://www.gurufocus.com/news/8910952/upcoming-earnings-reports-aurora-cannabis-acb-and-more

Trending Today

Aurora Cannabis Inc. Price History

12.05.2026 - ACB Stock was up 5.5%

• Despite a wider loss in the fourth quarter due to increased costs, Aurora Cannabis reported strong Q4 2026 financial results, exceeding revenue expectations and emphasizing growth in global medical cannabis.
• The announcement of a decline in fiscal year 2027 total net revenue and revised revenue forecasts for the second quarter of fiscal 2020 led to a negative investor reaction, causing a drop in share prices.
• The company's strategic priorities, including a shift towards high-margin global medical cannabis and international expansion, indicate a long-term growth strategy despite short-term revenue challenges.
• Aurora Cannabis's upcoming earnings report will be crucial in providing insights into its financial health and addressing concerns about profitability and growth, potentially influencing investor sentiment and market movement.

11.05.2026 - ACB Stock was down 14.5%

• ACB recorded record annual revenue and adjusted EBITDA, indicating positive financial growth.
• The recent acquisition of Safari Flower Company aligns with ACB's strategy to expand its medical cannabis product offerings.
• Despite the positive financial performance, concerns about profitability, growth, and internal controls have led to investor caution and a decrease in stock price.
• Anticipated revenue and adjusted EBITDA declines in the next fiscal year, driven by lower Canadian medical pricing, have influenced the bearish sentiment surrounding ACB's stock.

22.03.2026 - ACB Stock was up 6.5%

• Following a period of market underperformance, ACB demonstrated a notable bullish movement today.
• The acquisition of Safari Flower Company for $26.5 million appears to have boosted investor confidence in Aurora Cannabis.
• This strategic acquisition is anticipated to strengthen Aurora's presence in the premium cannabis sector and bolster its global market position, potentially fueling a positive trend in the stock.
• Analysts hold differing views on Aurora's financial status and growth potential, but the recent acquisition highlights the company's proactive efforts to expand its market share and product line.

05.05.2026 - ACB Stock was down 5.2%

• The downward movement in Aurora Cannabis Inc. (ACB) stock may be due to several factors:
• Despite intermittent upticks, the stock has consistently underperformed the market in recent days, suggesting a lack of investor confidence.
• The decline in stock value may be influenced by the company's financial performance and market positioning, notably the substantial drop from its 52-week high.
• While Aurora Cannabis has implemented initiatives like Strains for Heroes to support veterans, these efforts may not have sufficiently countered broader market challenges and investor uncertainties.
• The prevailing bearish outlook on the cannabis sector or specific company-related developments could also be contributing to the negative trajectory of ACB stock.

30.03.2026 - ACB Stock was up 5.1%

• Despite recent underperformance in the market, Aurora Cannabis saw a bullish movement today, potentially driven by its strategic expansion of high-potency medical cannabis products in key international markets.
• The projected significant growth in the U.S. cannabis market could have positively influenced investor sentiment towards Aurora Cannabis, as the company positions itself to capitalize on the expanding industry.
• Aurora Cannabis' focus on precision, diversification, and regulatory compliance in its product launches aligns well with the evolving trends in the medical cannabis sector, indicating a strategic advantage for the company.
• The improving operational trajectories and constructive earnings outlook, coupled with the company's expansion efforts, may have contributed to the bullish movement in Aurora Cannabis stock today.

23.03.2026 - ACB Stock was down 5.2%

• ACB stock displayed a significant downward movement today, contrasting with its recent positive showings.
• The acquisition of Safari Flower Company for C$26.5 million likely initially boosted investor confidence, contributing to the recent uptrend.
• Nevertheless, factors such as market volatility and broader economic conditions could have played a role in today's bearish movement, overshadowing the positive impact of the acquisition.
• Investor sentiment might have been influenced by uncertainties in the cannabis sector or profit-taking activities following recent gains, resulting in underperformance of the stock compared to the overall market today.

28.04.2026 - ACB Stock was up 6.2%

• Aurora Cannabis announcing its Q4 and fiscal year 2026 earnings call has created positive anticipation among investors, resulting in a bullish trend in the stock.
• The upcoming investor conference call hosted by the company's top executives to review financial results likely boosted shareholder confidence and contributed to the stock's bullish momentum.
• Despite a recent period of underperformance where Aurora Cannabis shares declined while the broader market rose, the market appears to be responding favorably to the future financial updates and strategic discussions planned by the company.
• The scheduled virtual annual meeting on August 7, 2026, demonstrates Aurora Cannabis' proactive approach in engaging with stakeholders, potentially strengthening investor sentiment and propelling the stock's upward movement.

28.04.2026 - ACB Stock was up 5.4%

• The stock saw a 2.81% decrease in performance, underperforming the market on Friday, despite displaying overall strong bullish movement.
• The announcement of an upcoming virtual annual meeting by Aurora Cannabis potentially contributed to positive investor sentiment and recent stock price gains.
• Prior to the drop on Friday, ACB experienced a three-day winning streak, indicating positive investor reaction to recent company developments and market conditions.
• ACB outperformed the market on Thursday, amidst favorable market conditions, suggesting that the stock's bullish movement was influenced by a combination of internal and external factors.

14.03.2026 - ACB Stock was up 5.8%

• ACB stock saw a 1.5% increase, amid diverse analyst outlooks and recent underperformance on quarterly financial projections.
• Traders on TradingView provided technical analyses pointing towards an optimistic future for ACB, highlighting key levels of resistance and support, chart configurations, and risk mitigation approaches.
• Despite trading below its highest point in a year, ACB demonstrated strength in today's market, underscoring its resilience in a volatile sector.
• With consecutive days of growth, ACB's upward trajectory signals growing positivity and investor engagement, buoying the stock price increase.

13.03.2026 - ACB Stock was up 5.2%

• The bullish movement in ACB today can be attributed to a combination of technical factors and market sentiment:
• Despite recent underperformance compared to the broader market, multiple traders on TradingView have identified bullish patterns like inverse head and shoulders, bull pennants, and symmetrical triangles, signaling a potential upward trend.
• The consecutive days of gains on Thursday and Wednesday, even though underperforming the market, have likely contributed to renewed investor confidence in ACB.
• The technical analysis, despite assigning a low rating, notes a decent setup pattern and reduced volatility, which might have attracted traders looking for short-term opportunities in a volatile market.

29.03.2026 - ACB Stock was down 5.2%

• The recent bearish movement in ACB stock could be linked to profit-taking following a two-day winning streak, with investors possibly aiming to secure their profits.
• Despite expanding its global medical cannabis product line, concerns regarding the company's weak cash-flow quality and poor technical momentum may have impacted market sentiment.
• While the U.S. cannabis market shows promising growth prospects, regulatory uncertainty and intensifying competition within the industry may be influencing the cautious outlook on Aurora Cannabis.
• Investors might be holding off on full commitment to the stock until seeing more concrete results from its strategic initiatives, potentially contributing to the observed bearish movement today.

20.04.2026 - ACB Stock was up 3.8%

• The bullish movement in ACB stock could be attributed to the news of being granted Plant Breeders' Rights for its two proprietary cannabis cultivars, Farm Gas and Driftwood Diesel. This recognition not only strengthens Aurora's position in the cannabis market but also highlights its commitment to innovation and product development.
• The upcoming investor conference call for its fourth quarter and fiscal year 2025 results might have generated positive investor sentiment, leading to increased buying activity and driving the stock price higher.
• Despite the recent underperformance and consecutive days of losses, the positive news surrounding Aurora Cannabis Inc.'s advancements in cannabis science and intellectual property rights seem to have reversed the downward trend and instilled confidence in investors.